Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29131107 | 0.85 | — | — | |
| SCHEMBL29120197 | 0.84 | — | — | |
| SCHEMBL22345561 | 0.81 | CYP3A4 (0.31) | — | |
| SCHEMBL29120194 | 0.79 | — | — | |
| SCHEMBL14244572 | 0.72 | CHRM1 (0.32) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL29131119 | 0.71 | — | — | |
| SCHEMBL2511230 | 0.71 | CYP3A4 (0.33) | — | |
| SCHEMBL28222137 | 0.70 | CHRM1 (0.33) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL19974061 | 0.69 | — | — | |
| SCHEMBL940772 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164623-A | Synthesis method of dialkyl phosphinate | 江苏利思德新材料股份有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117164623-A | Synthesis method of dialkyl phosphinate | 江苏利思德新材料股份有限公司 | 2023-12-05 | — | — | CN | disclosed |